查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1857608

永续医药包装市场：依包装类型、材料、药品类型、最终用户和技术划分－2025-2032年全球预测

Sustainable Pharmaceutical Packaging Market by Packaging Type, Material, Drug Type, End User, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，永续药品包装市场规模将达到 2,352.8 亿美元，复合年增长率为 13.45%。

主要市场统计数据
基准年 2024 857亿美元
预计年份：2025年 974.9亿美元
预测年份：2032年 2352.8亿美元
复合年增长率 (%) 13.45%

本文简要阐述了为何永续药品包装需要一种涵盖安全、监管和环境优先事项的综合营运方法。

药品包装处于病人安全、法规遵循、供应链韧性和环境保护的交会点。随着相关人员对产品完整性和永续性的要求越来越高，包装选择不仅影响营运成本和物流，也日益影响品牌信任度和监管机构的认可。本执行摘要了正在重塑整个药品价值链包装策略的根本性转变，重点阐述了材料创新、技术整合和政策动态如何共同作用，重新定义「适用包装」的含义。

永续材料、活性阻隔技术和数位化可追溯性的整合如何重新定义药品包装性能和供应商关係

受环境影响监管日益严格、材料创新日新月异以及数位化溯源解决方案普及等多重因素共同驱动，医药包装领域正经历一系列变革。在整个价值链中，人们正切实地从单一用途的包装转向兼具保护、延长保质期和循环利用功能的多功能係统。诸如可生物降解聚合物和增强玻璃配方等材料，不仅要评估其阻隔性能，还要评估其报废处理途径和碳排放影响。

评估近期关税调整和贸易政策转变如何促进包装行业的供应链本地化、供应商多元化和材料认证计划。

到2025年，关税的累积变动和贸易政策调整正在改变医药包装材料和组件的成本动态以及供应商的决策。对某些进口原料和组件征收更高的课税，促使下游企业重新评估总到岸成本、前置作业时间和库存策略。为此，许多企业正在加快供应商多元化，优先选择地理位置相近且垂直整合的合作伙伴，以减轻贸易摩擦和运费波动的影响。

综合細項分析揭示了包装类型、材料选择、药物配方、终端用户需求和新兴技术之间的交集，从而指南策略投资。

精细化的细分视角清楚地展现了创新与风险的交会点，从而明确了优先研发方向与采购管道。包装类型涵盖安瓿、泡壳包装、瓶装、软袋和管瓶，每种类型又细分为玻璃和塑胶安瓿、纸质和多层泡壳结构、玻璃和塑胶瓶、铝箔和纸质软袋以及玻璃和塑胶管瓶子类型。这些区分至关重要，因为不同包装形式的阻隔性能、灭菌相容性和回收途径差异显着。材料选择包括生物分解性塑胶，例如PHA、PLA和淀粉基聚合物；玻璃材料，例如硼硅酸、燧石玻璃和钠钙玻璃；金属，例如铝和钢；以及纸基基材，例如瓦楞纸和牛皮纸。这些选择需要在耐用性、渗透性、可回收性和生命週期足迹之间进行权衡。

影响美洲、欧洲、中东和非洲以及亚太市场包装决策的区域优先事项和监管环境

区域动态对包装设计、采购和技术应用的策略选择有显着影响。在美洲，监管机构的期望以及对永续性报告的强烈要求，正促使製造商和合约包装商投资于可回收包装形式，并与本土材料供应商建立合作关係。市场对低温运输可靠性和大型零售药局通路的重视，也推动了稳健的二次包装和可追溯性解决方案的发展。在欧洲、中东和非洲，政策驱动因素和生产者延伸责任框架正在加速可重复使用和可回收材料的普及，而严格的管理体制则要求进行有效的安全性和适用性测试。

市场领导如何协调垂直整合、共同开发伙伴关係、可追溯性投资和验证服务，从而在包装领域获得竞争优势？

医药包装生态系统中的主要企业正在采取不同但互补的策略，以克服性能、永续性和监管方面的复杂性。一些公司正在垂直整合材料生产和加工能力，以确保供应的连续性并缩短新材料的认证週期。另一些公司则专注于与聚合物创新者和玻璃製造商建立策略伙伴关係和共同开发契约，以加速高效环保材料的推出。投资于中试生产线和模组製造已成为缩短检验时间并限制资本投入的常用策略。

针对采购、研发和监管团队，制定有针对性的、可操作的措施，以在包装策略中平衡韧性、永续性和合规性。

产业领导者应采取组合策略，兼顾短期营运韧性与长期永续性转型。首先，应优先考虑供应商多元化，透过对地理位置相近的替代供应商进行资质认证，并对高风险材料采取双重采购安排，同时加快资质认证蓝图，以减少转换阻力。其次，应投资进行有针对性的材料替代试点项目，利用跨职能团队在实际稳定性及灭菌条件下评估可生物降解聚合物和先进玻璃配方，以加快技术检验并证明其符合监管要求。

采用透明的混合方法研究设计，结合专家访谈、供应链检验、技术评估和用例分析，确保获得可操作、可复製的洞见。

本研究采用混合方法，将专家质性见解与结构化的供应链分析和技术评估结合。主要研究包括对高级包装工程师、法规事务专家、采购负责人和供应商技术经理进行深入访谈，并辅以实地考察和虚拟研讨会，以检验材料性能声明和认证流程。次要研究包括对法规指南、技术标准、生命週期评估文献以及已发布的材料安全和合规数据进行系统性回顾，以支持主要研究结果并为风险框架提供基础。

本文对跨职能协作和渐进式实施对于实现包装产品安全和永续性目标至关重要的原因进行了批判性综合分析。

永续的药品包装不再是美好的愿景，而是与品质、合规性和企业责任息息相关的商业要务。材料创新、技术赋能的可追溯性以及不断变化的贸易动态正在重塑行业格局，这要求我们采用更灵活的伙伴关係以及更严格的检验流程。为了取得成功，包装决策必须从整体角度出发，并被视为跨职能的投资，它会影响产品安全、病患疗效和环境绩效。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 用于泡壳包装中控制释放的可生物降解聚合物涂层
  • 将智慧感测器整合到可回收包装中，用于即时监测药品稳定性。
  • 开发用于注射管瓶防潮保护的植物来源纤维素薄膜
  • 高密度聚苯乙烯药用容器闭合迴路回收系统的标准化
  • 引入轻质玻璃替代品，以减少注射剂包装的碳足迹
  • 利用人工智慧优化供应链，最大限度地减少包装废弃物和碳排放
  • 鼓励在药品二级包装中使用消费后回收材料的监管激励措施
  • 先进的可食用涂层技术，可增强稳定性并减少包装废弃物

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依包装类型分類的永续医药包装市场

  • 安瓿
    • 玻璃安瓿
    • 塑胶安瓿
  • 泡壳包装
    • 纸包
    • PVC铝箔包装
    • PVDC 电池组
  • 瓶子
    • 玻璃瓶
    • 塑胶瓶
  • 小袋
    • 铝箔袋
    • 纸袋
  • 管瓶
    • 玻璃管瓶
    • 塑胶管瓶

第九章 依材料分類的永续医药包装市场

  • 生物分解性塑胶
    • PHA
    • PLA
    • 淀粉基聚合物
  • 玻璃
    • 硼硅酸
    • 燧石
    • 苏打石灰
  • 金属
    • 铝
    • 钢
  • 纸板
    • 纸板
    • 牛皮纸

第十章 依药品类型分類的永续药品包装市场

  • 液体
    • 解决方案
    • 暂停
  • 半固态
    • 奶油
    • 凝胶
    • 软膏
  • 固态剂型
    • 胶囊
    • 药片

第十一章永续医药包装市场：依最终用户划分

  • 诊所
  • 医院
  • 网路药房
  • 研究所
  • 零售药房

第十二章永续医药包装市场（依技术划分）

  • 活性包装
    • 乙烯清除剂
    • 氧气清除剂
  • 智慧包装
    • NFC
    • QR码
    • RFID
  • 调气包装
    • 调气包装容器
    • 调气包装膜
  • 真空包装
    • 盖膜
    • 真空袋

第十三章永续医药包装市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章永续医药包装市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国永续医药包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Amcor plc
    • Berry Global Group, Inc.
    • Mondi plc
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • AptarGroup, Inc.
    • SCHOTT AG
    • Constantia Flexibles Group GmbH
    • Tekni-Plex, Inc.
    • ALPLA Werke Alwin Lehner GmbH & Co KG
Product Code: MRR-67236922860E

The Sustainable Pharmaceutical Packaging Market is projected to grow by USD 235.28 billion at a CAGR of 13.45% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 85.70 billion
Estimated Year [2025] USD 97.49 billion
Forecast Year [2032] USD 235.28 billion
CAGR (%) 13.45%

A concise orientation to why sustainable pharmaceutical packaging now demands integrated operational approaches across safety, regulation, and environmental priorities

Pharmaceutical packaging sits at the intersection of patient safety, regulatory compliance, supply chain resilience, and environmental stewardship. As stakeholders demand higher standards for product integrity and sustainability, packaging choices increasingly determine not only operational cost and logistics, but also brand trust and regulatory acceptance. This executive summary distills the structural shifts reshaping packaging strategies across the pharmaceutical value chain, highlighting how material innovation, technology integration, and policy dynamics coalesce to redefine what "fit for purpose" packaging entails.

The analysis that follows frames both immediate and strategic considerations for manufacturers, contract packagers, material suppliers, and healthcare providers. It emphasizes pragmatic pathways to balance product protection with environmental responsibility, showing how firms can reduce systemic risk without compromising compliance. By synthesizing technological trajectories, supply chain pressures, and regional policy contexts, the summary equips leaders with an actionable perspective to align short-term operational choices with longer-term sustainability commitments. Readers should expect clear, implementable insights intended to guide sourcing, R&D prioritization, and cross-functional coordination.

How convergence of sustainable materials, active barrier technologies, and digital traceability is redefining pharmaceutical packaging performance and supplier relationships

The pharmaceutical packaging landscape is undergoing a series of transformative shifts driven by converging forces: heightened regulatory scrutiny for environmental impact, rapid material innovation, and the proliferation of digital traceability solutions. Across the value chain, there is a tangible move from single-purpose containers toward multifunctional systems that combine protection, extended shelf life, and circularity. Materials such as biodegradable polymers and enhanced glass formulations are being evaluated not only for barrier performance but also for end-of-life pathways and carbon implications.

Parallel to material change, packaging technologies that actively manage product micro-environments and provide real-time information are gaining traction. Active packaging components like oxygen and ethylene scavengers and intelligent layers enabled by NFC and RFID are being integrated to improve stability and reduce waste. Moreover, manufacturers increasingly favor modular design and compatibility with sterilization methods to streamline manufacturing and logistics. These shifts are prompting a re-evaluation of supplier relationships, quality assurance protocols, and capital allocation decisions, as firms balance the imperative for sustainability with the uncompromising requirements of patient safety and regulatory compliance.

Assessing how recent tariff adjustments and trade policy shifts have catalyzed supply chain localization, supplier diversification, and material qualification programs in packaging

Cumulative tariff activity and trade policy adjustments in 2025 have altered cost dynamics and supplier decisions for pharmaceutical packaging materials and components. Increased levies on certain imported raw materials and components have encouraged downstream players to reassess total landed cost, lead times, and inventory strategies. In response, many organizations have accelerated supplier diversification efforts, prioritizing geographically proximate and vertically integrated partners to mitigate exposure to trade friction and freight volatility.

The tariff-driven rebalancing has also amplified interest in material substitution where domestic availability is strong; for example, sourcing alternatives to certain coated films and metal components has become more attractive when tariff differentials erode cost advantages of long-distance suppliers. At the same time, regulatory compliance considerations and the need for validated material equivalence mean that transitions cannot be purely cost-driven. Firms have increased investment in qualification protocols and in collaborative trials with material suppliers to ensure that changes in sourcing do not compromise drug stability or packaging integrity. Ultimately, trade measures in 2025 served as a catalyst for greater supply chain localization, stronger supplier partnerships, and more disciplined scenario planning across procurement and regulatory teams.

An integrated segmentation analysis revealing where packaging types, material choices, drug formulations, end-user needs, and emerging technologies intersect to guide strategic investment

A granular segmentation lens clarifies where innovation and risk converge and illuminates priority pathways for development and procurement. Packaging types span ampoules, blister packs, bottles, pouches, and vials, each with subtypes such as glass versus plastic ampoules, paper and multi-layer blister constructions, glass and plastic bottles, foil and paper pouches, and glass and plastic vials; these distinctions matter because barrier needs, sterilization compatibility, and recycling routes vary significantly across formats. Material choices encompass biodegradable plastics-including PHA, PLA, and starch-based polymers-glass variants like borosilicate, flint, and soda lime, metals such as aluminum and steel, and paper-based substrates including corrugated board and kraft paper; these materials drive trade-offs between durability, permeability, recyclability, and life-cycle footprint.

Drug type segmentation-liquid dosage formulations (solutions and suspensions), semi-solid forms (creams, gels, ointments), and solid dosages (capsules and tablets)-creates distinct stability demands that influence container selection, barrier specification, and secondary packaging. End users range from clinics and hospitals to online and retail pharmacies, and research laboratories, each imposing unique handling, storage, and patient-facing requirements that shape packaging ergonomics and labeling. Technology-driven categories include active packaging with ethylene and oxygen scavengers, intelligent solutions leveraging NFC, QR, and RFID for authentication and data capture, modified atmosphere options via MAP containers and films, and vacuum systems employing lidding films and vacuum pouches; selecting among these technologies requires aligning functional performance with cost, regulatory considerations, and sustainability objectives. By examining these segments together, firms can prioritize innovation investments where material and format transitions yield the greatest impact on performance, compliance, and environmental outcomes.

Regional priorities and regulatory contexts that shape packaging decisions across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics substantially influence strategic choices in packaging design, sourcing, and technology adoption. In the Americas, regulatory expectations and strong demand for sustainability reporting have prompted manufacturers and contract packagers to invest in recyclable formats and to pursue partnerships with domestic material suppliers; the market's emphasis on cold-chain reliability and large retail pharmacy channels also favors robust secondary packaging and traceability solutions. In Europe, Middle East & Africa, policy drivers and extended producer responsibility frameworks are accelerating the adoption of reusable and recyclable materials, while stringent regulatory regimes insist on validated safety and compatibility testing; manufacturers operating in this region often prioritize materials with clear end-of-life pathways and suppliers that can provide lifecycle documentation.

Across Asia-Pacific, rapid growth in local pharmaceutical manufacturing and a diverse range of end-user infrastructures have led to a dual focus on cost-effective materials and scalable technology solutions. In several markets, novel biodegradable polymers are being trialed at scale, and there is brisk adoption of intelligent labeling to support anti-counterfeiting and remote patient engagement. Regional supply chains in Asia-Pacific also play a pivotal role in global sourcing, making supplier qualification and quality assurance critical for multinational firms that rely on components produced there. Together, these regional nuances require multinational packaging strategies that balance centralized standards with localized execution and supplier ecosystems.

How market leaders are aligning vertical integration, co-development partnerships, traceability investments, and validation services to gain competitive advantage in packaging

Leading companies in the pharmaceutical packaging ecosystem are pursuing distinct but complementary strategies to navigate performance, sustainability, and regulatory complexity. Some players are vertically integrating material production and converting capabilities to secure supply continuity and to reduce qualification cycles for new materials. Others focus on strategic partnerships and co-development agreements with polymer innovators and glass manufacturers to accelerate the introduction of validated, low-impact materials. Investment in pilot lines and modular manufacturing has become a common tactic to shorten time-to-validation while limiting capital exposure.

Across the competitive landscape, firms are differentiating through certification and traceability credentials, leveraging technologies like RFID and cryptographic QR implementations to meet anti-counterfeiting and provenance demands. Another common thread is the emphasis on technical service: suppliers offering comprehensive validation support, stability study collaboration, and regulatory dossier assistance are gaining preference among pharmaceutical companies. Mergers and targeted acquisitions are also shaping the sector, enabling buyers to expand technology portfolios and regional footprints. Collectively, these company-level tactics reflect a shift from transactional supply models to partnership-focused engagements that align commercial terms with long-term technical collaboration and sustainability outcomes.

Targeted, actionable measures for procurement, R&D, and regulatory teams to balance resilience, sustainability, and compliance in packaging strategies

Industry leaders should adopt a portfolio approach that balances immediate operational resilience with longer-term sustainability transitions. First, prioritize supplier diversification by qualifying alternative vendors across regionally proximate geographies and by establishing dual-sourcing arrangements for high-risk materials; simultaneously develop accelerated qualification roadmaps that reduce switching friction. Next, invest in targeted material substitution pilots that evaluate biodegradable polymers and advanced glass formulations under real-world stability and sterilization conditions, using cross-functional teams to expedite technical validation and to document regulatory equivalence.

Leaders should also scale intelligent packaging pilots that deliver measurable returns, such as reduced counterfeiting risk, improved cold-chain monitoring, or lower product loss, then expand those solutions where ROI is demonstrated. Implement robust end-of-life strategies by collaborating with recycling value chains and by specifying mono-material constructions when possible to enhance recyclability. To manage trade and tariff exposure, enact scenario-based procurement plans and maintain buffer inventories for critical components while negotiating flexible commercial terms. Finally, embed clear sustainability metrics into supplier scorecards and purchasing decisions, align R&D roadmaps with regulatory trajectories, and maintain active dialogue with regulators and industry consortia to shape practical, harmonized standards.

A transparent mixed-methods research design combining expert interviews, supply chain validation, technical assessments, and case studies to ensure practical, reproducible insights

This research employs a mixed-methods approach that synthesizes qualitative expert insight with structured supply chain analysis and technical assessment. Primary research consisted of in-depth interviews with senior packaging engineers, regulatory affairs specialists, procurement leads, and supplier technical managers, complemented by site visits and virtual workshops to validate material performance claims and qualification workflows. Secondary research included a systematic review of regulatory guidance, technical standards, lifecycle assessment literature, and published material safety and compatibility data to corroborate primary findings and to inform risk frameworks.

Data triangulation was used throughout to reconcile differing perspectives and to ensure that technical recommendations reflect real-world constraints. Case studies were developed to illustrate successful transitions in materials and technologies, including detailed accounts of validation pathways and commercial arrangements. Limitations include variability in regional regulatory timelines and emerging data on novel biodegradable polymers; where evidence remains nascent, recommendations emphasize pilot testing and staged qualification. The methodology prioritizes reproducibility and transparency, and documentation is provided so practitioners can adapt evaluation sequences to their internal governance and risk tolerance.

A decisive synthesis of why cross-functional alignment and phased implementation are essential to realize both product safety and sustainability objectives in packaging

Sustainable pharmaceutical packaging is no longer an aspirational goal; it is an operational imperative that intersects quality, compliance, and corporate responsibility. The landscape is being reshaped by material innovations, technology-enabled traceability, and shifting trade dynamics that together demand more agile sourcing, stronger supplier partnerships, and rigorous validation practices. Success requires organizations to think holistically about packaging decisions, treating them as cross-functional investments that affect product safety, patient outcomes, and environmental performance.

By integrating the segmentation insights, regional nuances, and company tactics described above, decision-makers can construct phased strategies that mitigate near-term risks while building capacity for long-term transformation. Incremental pilots, robust supplier qualification, and targeted technology deployment will allow firms to both satisfy regulatory requirements and achieve measurable sustainability improvements. The most resilient companies will be those that align commercial incentives with technical collaboration and that institutionalize continuous learning between procurement, R&D, and regulatory teams.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of biodegradable polymer coatings for controlled drug release in blister packs
  • 5.2. Integration of smart sensors in recyclable packaging to monitor drug stability in real time
  • 5.3. Development of plant-based cellulose films for moisture barrier protection in injectable vials
  • 5.4. Standardization of closed loop recycling systems for high-density polyethylene drug containers
  • 5.5. Implementation of lightweight glass alternatives to reduce carbon footprint in parenteral packaging
  • 5.6. Use of AI-driven supply chain optimization to minimize packaging waste and carbon emissions
  • 5.7. Regulatory incentives for using post-consumer recycled content in pharmaceutical secondary packaging
  • 5.8. Advancements in edible coating technologies to enhance stability and reduce packaging disposables

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sustainable Pharmaceutical Packaging Market, by Packaging Type

  • 8.1. Ampoules
    • 8.1.1. Glass Ampoules
    • 8.1.2. Plastic Ampoules
  • 8.2. Blister Packs
    • 8.2.1. Paper Packs
    • 8.2.2. Pvc Aluminum Packs
    • 8.2.3. Pvdc Packs
  • 8.3. Bottles
    • 8.3.1. Glass Bottles
    • 8.3.2. Plastic Bottles
  • 8.4. Pouches
    • 8.4.1. Foil Pouches
    • 8.4.2. Paper Pouches
  • 8.5. Vials
    • 8.5.1. Glass Vials
    • 8.5.2. Plastic Vials

9. Sustainable Pharmaceutical Packaging Market, by Material

  • 9.1. Biodegradable Plastics
    • 9.1.1. Pha
    • 9.1.2. Pla
    • 9.1.3. Starch Based Polymers
  • 9.2. Glass
    • 9.2.1. Borosilicate
    • 9.2.2. Flint
    • 9.2.3. Soda Lime
  • 9.3. Metal
    • 9.3.1. Aluminum
    • 9.3.2. Steel
  • 9.4. Paper Cardboard
    • 9.4.1. Corrugated Board
    • 9.4.2. Kraft Paper

10. Sustainable Pharmaceutical Packaging Market, by Drug Type

  • 10.1. Liquid Dosage
    • 10.1.1. Solutions
    • 10.1.2. Suspensions
  • 10.2. Semi Solid Dosage
    • 10.2.1. Creams
    • 10.2.2. Gels
    • 10.2.3. Ointments
  • 10.3. Solid Dosage
    • 10.3.1. Capsules
    • 10.3.2. Tablets

11. Sustainable Pharmaceutical Packaging Market, by End User

  • 11.1. Clinics
  • 11.2. Hospitals
  • 11.3. Online Pharmacies
  • 11.4. Research Laboratories
  • 11.5. Retail Pharmacies

12. Sustainable Pharmaceutical Packaging Market, by Technology

  • 12.1. Active Packaging
    • 12.1.1. Ethylene Scavengers
    • 12.1.2. Oxygen Scavengers
  • 12.2. Intelligent Packaging
    • 12.2.1. Nfc
    • 12.2.2. Qr Code
    • 12.2.3. Rfid
  • 12.3. Modified Atmosphere Packaging
    • 12.3.1. Map Containers
    • 12.3.2. Map Films
  • 12.4. Vacuum Packaging
    • 12.4.1. Lidding Films
    • 12.4.2. Vacuum Pouches

13. Sustainable Pharmaceutical Packaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sustainable Pharmaceutical Packaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sustainable Pharmaceutical Packaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Amcor plc
    • 16.3.2. Berry Global Group, Inc.
    • 16.3.3. Mondi plc
    • 16.3.4. Gerresheimer AG
    • 16.3.5. West Pharmaceutical Services, Inc.
    • 16.3.6. AptarGroup, Inc.
    • 16.3.7. SCHOTT AG
    • 16.3.8. Constantia Flexibles Group GmbH
    • 16.3.9. Tekni-Plex, Inc.
    • 16.3.10. ALPLA Werke Alwin Lehner GmbH & Co KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVC ALUMINUM PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PVDC PACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC BOTTLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FOIL POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER POUCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLASTIC VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BIODEGRADABLE PLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PHA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STARCH BASED POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY BOROSILICATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY FLINT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SODA LIME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY PAPER CARDBOARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CORRUGATED BOARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY KRAFT PAPER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SEMI SOLID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SIZE, BY CLINICS, BY COUN